2 weeks Ago Compass Therapeutics ( NASDAQ: CMPS ) filed for $300M mixed securities shelf. Filing More on COMPASS Pathways ADS Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision Psychedelic Stocks: Focus On Their Cash Trials for psychedelic drug candidate for PTSD under scrutiny by FDA - report.
